Strategic Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.32M Sell
7,131
-2,704
-27% -$499K 0.13% 81
2025
Q1
$2.06M Sell
9,835
-359
-4% -$75.2K 0.22% 62
2024
Q4
$1.81M Buy
10,194
+32
+0.3% +$5.69K 0.19% 71
2024
Q3
$2.01M Sell
10,162
-31
-0.3% -$6.12K 0.22% 67
2024
Q2
$1.75M Sell
10,193
-24
-0.2% -$4.12K 0.21% 68
2024
Q1
$1.86M Buy
10,217
+45
+0.4% +$8.2K 0.24% 61
2023
Q4
$1.58M Sell
10,172
-638
-6% -$98.9K 0.23% 66
2023
Q3
$1.61M Buy
10,810
+43
+0.4% +$6.41K 0.27% 55
2023
Q2
$1.45M Buy
10,767
+91
+0.9% +$12.3K 0.2% 50
2023
Q1
$1.7M Sell
10,676
-606
-5% -$96.6K 0.31% 53
2022
Q4
$1.82M Sell
11,282
-4
-0% -$646 0.38% 47
2022
Q3
$1.52M Buy
11,286
+172
+2% +$23.1K 0.34% 53
2022
Q2
$1.7M Sell
11,114
-31
-0.3% -$4.75K 0.34% 50
2022
Q1
$1.81M Sell
11,145
-2,802
-20% -$454K 0.34% 52
2021
Q4
$1.89M Buy
13,947
+569
+4% +$77K 0.36% 52
2021
Q3
$1.44M Buy
13,378
+1,783
+15% +$192K 0.32% 63
2021
Q2
$1.31M Buy
11,595
+3,248
+39% +$366K 0.3% 69
2021
Q1
$903K Buy
8,347
+1,215
+17% +$131K 0.23% 88
2020
Q4
$764K Sell
7,132
-2,337
-25% -$250K 0.22% 91
2020
Q3
$828K Sell
9,469
-1,174
-11% -$103K 0.28% 68
2020
Q2
$1.05M Buy
10,643
+673
+7% +$66.1K 0.39% 55
2020
Q1
$760K Buy
9,970
+435
+5% +$33.2K 0.35% 61
2019
Q4
$844K Buy
9,535
+314
+3% +$27.8K 0.35% 61
2019
Q3
$698K Buy
9,221
+1,167
+14% +$88.3K 0.33% 58
2019
Q2
$586K Buy
8,054
+2,222
+38% +$162K 0.32% 59
2019
Q1
$470K Buy
5,832
+933
+19% +$75.2K 0.32% 62
2018
Q4
$452K Buy
+4,899
New +$452K 0.41% 56